Nutex Health Inc. NUTX
Regular-session close
After hours · Nov 19, 7:30 PM ET
- YTD
- -1.53%
- 1 year
- +44.49%
5D -13.49 (-7.67%)
- Market cap
- 1.11B
- Revenue (ttm)
- 796.53M
- Profit margin
- 20.68%
- EPS (ttm)
- 23.11
- Shares out
- 6.86M
- P/E ratio
- 7.01
- Forward P/E
- 7.97
- YTD return
- -1.53%
- 1-year return
- +44.49%
- 50-day average
- 201.01
- Volume
- 105.02K
- Avg volume
- 149.10K
- Open
- 174.44
- Previous close
- 172.74
- Day's range
- 161.67 – 176.11
- 52-week range
- 83.99 – 226.16
- Beta
- 2.01
- Analysts
- Strong Buy
- Price target
- 313.67 (+93.5%)
- Earnings date
- Mar 4, 2027
Key statistics
- 200-day average
- 152.28
- Enterprise value
- 1.41B
- Price / sales
- 1.40
- Price / book
- 2.55
- Revenue growth
- -18.70%
- Free cash flow
- 157.44M
- Total cash
- 249.91M
- Total debt
- 364.98M
- Return on equity
- 47.61%
- Short % of float
- 26.90%
Fundamental scorecard
14 of 25 checks passed on NUTX’s reported financials
14of 25 checks passed
- Value 3 of 5
- Growth 2 of 5
- Profitability 4 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: strong buy
- Target (low)
- 250.00
- Target (mean)
- 313.67
- Target (high)
- 357.00
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Mar 4, 2027
Expected Mar 4, 2027. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 4, 2027 | Dec 30, 2026 | 5.87 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | 5.54 | 5.71 | +0.17 | +3.07% |
| Aug 6, 2026 | Jun 30, 2026 | 4.95 | 9.38 | +4.43 | +89.49% |
| Apr 30, 2026 | Mar 31, 2026 | 3.99 | 6.52 | +2.53 | +63.41% |
| Mar 5, 2026 | Dec 31, 2025 | 5.56 | 1.61 | -3.95 | -71.04% |
| Nov 19, 2025 | Sep 30, 2025 | 1.81 | 7.76 | +5.95 | +328.73% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 9, 2026 | Lake Street | main | Buy | Buy |
| Nov 9, 2026 | B. Riley Securities | main | Buy | Buy |
| Oct 26, 2026 | Ladenburg Thalmann | init | — | Buy |
| Sep 25, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 4, 2026 | B. Riley Securities | main | Buy | Buy |
| Aug 11, 2026 | Lake Street | main | Buy | Buy |
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- nutexhealth.com
News
Nutex Health Declares First Dividend as a Public Company Lake Street Maintains Buy on Nutex Health, Raises Price Target to $333
NUTX Q3 Earnings Call Highlights Reimbursement and Hospital Growth B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $357
Nutex Health Named a 2026 Houston Top Workplace by Houston Chronicle
Nutex Health (NASDAQ:NUTX) Shares Gap Down – Time to Sell?
Nutex Health Inc. (NUTX) Q3 2026 Earnings Call Transcript
Nutex Health Q3 Earnings Call Highlights
Nutex Health Inc. (NUTX) Q3 Earnings and Revenues Beat Estimates
NUTEX HEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Your note
Sign in to keep a note on NUTX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATES JON CHRISTIAN | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 9, 2026 | 8,305 |
| CHANG MICHAEL L | Officer | Conversion of Exercise of derivative security | Mar 9, 2026 | 0 |
| DETILLIO JOSHUA | Chief Operating Officer | Conversion of Exercise of derivative security | Feb 27, 2025 | 6,481 |
| GRENAS CHERYL YVONNE | Director | Conversion of Exercise of derivative security | Jul 30, 2026 | 670 |
| HOSSEINION WARREN | President | Purchase | Mar 18, 2026 | 7,765 |
| JAUMOT FRANK E | Director | Conversion of Exercise of derivative security | Jul 30, 2026 | 753 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pertento Partners LLP | 7.57% | 519,188 | 84.16M | Sep 29, 2026 |
| Blackrock Inc. | 5.75% | 394,228 | 63.90M | Sep 29, 2026 |
| American Century Companies Inc | 4.72% | 323,842 | 52.49M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 2.89% | 198,161 | 32.12M | Sep 29, 2026 |
| State Street Corporation | 1.97% | 135,347 | 21.94M | Sep 29, 2026 |
| Geode Capital Management, LLC | 1.85% | 127,185 | 20.62M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 3.94% | 270,448 | 43.84M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.23% | 153,182 | 24.83M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.90% | 130,223 | 21.11M | Sep 29, 2026 |
| Bexil Investment Trust | 0.90% | 62,000 | 10.05M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.84% | 57,700 | 9.35M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.80% | 54,999 | 8.92M | Aug 30, 2026 |
